News APP

NewsApp (Free)

Read news as it happens
Download NewsApp

Available on  gplay

This article was first published 19 years ago
Home  » Business » Dr Reddy's gets USFDA nod for glimepiride

Dr Reddy's gets USFDA nod for glimepiride

Source: PTI
October 10, 2005 12:50 IST
Get Rediff News in your Inbox:
Hyderabad based Dr Reddy's Laboratories has received approval from the US Food and Drugs Administration for multiple strengths of anti-diabetes drug glimepiride tablets.

According to information available on the USFDA website, glimeperide is available in stengths of 1 mg, 2 mg and 4 mg. The drug is a generic version of Sanofi-Aventis' Amaryl.

Dr Reddy's has also recieved tentative approval from the USFDA for anti-cholesterol drug pravastatin sodium tablets in multiple strengths. The drug is a generic version of Bristol-Myers Squibb Co's Pravachol.

Get Rediff News in your Inbox:
Source: PTI© Copyright 2024 PTI. All rights reserved. Republication or redistribution of PTI content, including by framing or similar means, is expressly prohibited without the prior written consent.
 

Moneywiz Live!